atai Life Sciences Appoints New Chief Financial Officer and Chief Medical Officer

Articles | December 17, 2020

atai Life Sciences, a global biotech company developing psychedelic and non-psychedelic compounds for various mental health indications, has announced the appointment of Greg Weaver as Chief Financial Officer (CFO) and Rolando Gutierrez-Esteinou as Chief Medical Officer (CMO). Read More